{"data":[{"accessionNo":"0001104659-26-121888","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001513525","issuerName":"Azora Therapeutics, Inc.","ticker":"ADIL","cusip":"054800107","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-11-02","reportingPerson":"Matthew D. Perry","reportingCik":null,"personType":"HC,IN","sharesOwned":655975,"percentOfClass":4.99,"filedAt":"2026-11-03","canonicalUrl":"https://xoomar.com/markets/stocks/adil"},{"accessionNo":"0001104659-26-121888","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001513525","issuerName":"Azora Therapeutics, Inc.","ticker":"ADIL","cusip":"054800107","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-11-02","reportingPerson":"Coastlands Capital LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":655975,"percentOfClass":4.99,"filedAt":"2026-11-03","canonicalUrl":"https://xoomar.com/markets/stocks/adil"},{"accessionNo":"0001104659-26-121888","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001513525","issuerName":"Azora Therapeutics, Inc.","ticker":"ADIL","cusip":"054800107","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-11-02","reportingPerson":"Coastlands Capital GP LLC","reportingCik":null,"personType":"OO","sharesOwned":655975,"percentOfClass":4.99,"filedAt":"2026-11-03","canonicalUrl":"https://xoomar.com/markets/stocks/adil"},{"accessionNo":"0001104659-26-121888","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001513525","issuerName":"Azora Therapeutics, Inc.","ticker":"ADIL","cusip":"054800107","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-11-02","reportingPerson":"Coastlands Capital Partners LP","reportingCik":null,"personType":"PN","sharesOwned":655975,"percentOfClass":4.99,"filedAt":"2026-11-03","canonicalUrl":"https://xoomar.com/markets/stocks/adil"},{"accessionNo":"0001104659-26-121888","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001513525","issuerName":"Azora Therapeutics, Inc.","ticker":"ADIL","cusip":"054800107","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-11-02","reportingPerson":"Coastlands Capital LP","reportingCik":null,"personType":"IA,PN","sharesOwned":655975,"percentOfClass":4.99,"filedAt":"2026-11-03","canonicalUrl":"https://xoomar.com/markets/stocks/adil"},{"accessionNo":"0001104659-26-079983","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001513525","issuerName":"Adial Pharmaceuticals, Inc.","ticker":"ADIL","cusip":"00688A304","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-24","reportingPerson":"Coastlands Capital LP","reportingCik":null,"personType":"IA,PN","sharesOwned":373322,"percentOfClass":14.22,"filedAt":"2026-07-01","canonicalUrl":"https://xoomar.com/markets/stocks/adil"},{"accessionNo":"0001104659-26-079983","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001513525","issuerName":"Adial Pharmaceuticals, Inc.","ticker":"ADIL","cusip":"00688A304","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-24","reportingPerson":"Coastlands Capital Partners LP","reportingCik":null,"personType":"PN","sharesOwned":373322,"percentOfClass":14.22,"filedAt":"2026-07-01","canonicalUrl":"https://xoomar.com/markets/stocks/adil"},{"accessionNo":"0001104659-26-079983","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001513525","issuerName":"Adial Pharmaceuticals, Inc.","ticker":"ADIL","cusip":"00688A304","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-24","reportingPerson":"Coastlands Capital GP LLC","reportingCik":null,"personType":"OO","sharesOwned":373322,"percentOfClass":14.22,"filedAt":"2026-07-01","canonicalUrl":"https://xoomar.com/markets/stocks/adil"},{"accessionNo":"0001104659-26-079983","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001513525","issuerName":"Adial Pharmaceuticals, Inc.","ticker":"ADIL","cusip":"00688A304","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-24","reportingPerson":"Coastlands Capital LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":373322,"percentOfClass":14.22,"filedAt":"2026-07-01","canonicalUrl":"https://xoomar.com/markets/stocks/adil"},{"accessionNo":"0001104659-26-079983","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001513525","issuerName":"Adial Pharmaceuticals, Inc.","ticker":"ADIL","cusip":"00688A304","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-24","reportingPerson":"Matthew D. Perry","reportingCik":null,"personType":"HC,IN","sharesOwned":373322,"percentOfClass":14.22,"filedAt":"2026-07-01","canonicalUrl":"https://xoomar.com/markets/stocks/adil"},{"accessionNo":"0001104659-26-077127","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001513525","issuerName":"Adial Pharmaceuticals, Inc.","ticker":"ADIL","cusip":"00688A304","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-17","reportingPerson":"Coastlands Capital LP","reportingCik":null,"personType":"IA,PN","sharesOwned":262167,"percentOfClass":9.98,"filedAt":"2026-06-24","canonicalUrl":"https://xoomar.com/markets/stocks/adil"},{"accessionNo":"0001104659-26-077127","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001513525","issuerName":"Adial Pharmaceuticals, Inc.","ticker":"ADIL","cusip":"00688A304","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-17","reportingPerson":"Coastlands Capital Partners LP","reportingCik":null,"personType":"PN","sharesOwned":262167,"percentOfClass":9.98,"filedAt":"2026-06-24","canonicalUrl":"https://xoomar.com/markets/stocks/adil"},{"accessionNo":"0001104659-26-077127","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001513525","issuerName":"Adial Pharmaceuticals, Inc.","ticker":"ADIL","cusip":"00688A304","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-17","reportingPerson":"Coastlands Capital GP LLC","reportingCik":null,"personType":"OO","sharesOwned":262167,"percentOfClass":9.98,"filedAt":"2026-06-24","canonicalUrl":"https://xoomar.com/markets/stocks/adil"},{"accessionNo":"0001104659-26-077127","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001513525","issuerName":"Adial Pharmaceuticals, Inc.","ticker":"ADIL","cusip":"00688A304","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-17","reportingPerson":"Coastlands Capital LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":262167,"percentOfClass":9.98,"filedAt":"2026-06-24","canonicalUrl":"https://xoomar.com/markets/stocks/adil"},{"accessionNo":"0001104659-26-077127","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001513525","issuerName":"Adial Pharmaceuticals, Inc.","ticker":"ADIL","cusip":"00688A304","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-17","reportingPerson":"Matthew D. Perry","reportingCik":null,"personType":"HC,IN","sharesOwned":262167,"percentOfClass":9.98,"filedAt":"2026-06-24","canonicalUrl":"https://xoomar.com/markets/stocks/adil"},{"accessionNo":"0001172661-26-002114","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001513525","issuerName":"Adial Pharmaceuticals, Inc.","ticker":"ADIL","cusip":"00688A304","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Armistice Capital, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":274139,"percentOfClass":4.99,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/adil"},{"accessionNo":"0001172661-26-002114","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001513525","issuerName":"Adial Pharmaceuticals, Inc.","ticker":"ADIL","cusip":"00688A304","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Steven Boyd","reportingCik":null,"personType":"HC,IN","sharesOwned":274139,"percentOfClass":4.99,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/adil"},{"accessionNo":"0001172661-26-001297","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001513525","issuerName":"ADIAL PHARMACEUTICALS","ticker":"ADIL","cusip":null,"securityClass":"Common stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Armistice Capital, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":2799643,"percentOfClass":9.99,"filedAt":"2026-02-18","canonicalUrl":"https://xoomar.com/markets/stocks/adil"},{"accessionNo":"0001172661-26-001297","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001513525","issuerName":"ADIAL PHARMACEUTICALS","ticker":"ADIL","cusip":null,"securityClass":"Common stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Steven Boyd","reportingCik":null,"personType":"HC,IN","sharesOwned":2799643,"percentOfClass":9.99,"filedAt":"2026-02-18","canonicalUrl":"https://xoomar.com/markets/stocks/adil"}],"updatedAt":"2026-11-04T03:24:18.963Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/adil","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}